{"ORPHApacket":[{"ORPHApacketID":"164726","date":"2019-12-05 23:03:37","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"164726","Name":[{"lang":"en","label":"Acute myeloid leukemia and myelodysplastic syndromes related to radiation"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_164726","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Radiation-induced disorder"}],"ORPHA":"521132","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_521132"},{"Name":[{"lang":"en","label":"Therapy related acute myeloid leukemia and myelodysplastic syndrome"}],"ORPHA":"86846","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_86846"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"A subgroup of therapy-related myeloid neoplasms (t-MN), associated with treatment of an unrelated neoplastic disease with radiation. The neoplastic cells typically harbor unbalanced aberrations of chromosomes 5 and 7 (monosomy 5\/del(5q) and monosomy 7\/del(7q)) or a complex karyotype. Patients frequently present with multilineage dysplasia and cytopenias 5-10 years after exposure."}],"SynonymList":[{"count":"1","Synonym":[{"lang":"en","label":"AML and myelodysplastic syndromes related to radiation"}]}]}]}